Avicanna announces medical cannabis real world evidence study

Avicanna announced a large-scale medical cannabis real world evidence study through the MyMedi.ca medical cannabis care platform. The Study is to be led by Hance Clarke, MD, FRCPC, PhD. Dr. Clarke is the current President of The Canadian Pain Society and the Canadian Consortium for the Investigation of Cannabinoids. The prospective, non-interventional, observational study aims to enroll 1,000 patients across the country to understand the potential therapeutic use of medical cannabis and potential impact of medical cannabis on pain, sleep, anxiety, depression, and epilepsy. Utilizing validated questionnaires, the study seeks to understand the potential impact of various medical cannabis products and evaluate the change in use of concomitant medication over a 24-week duration. The study was originally initiated by Medical Cannabis by Shoppers and was part of Avicanna’s commitment to provide continuation of care to the platforms’ patients but also the advancement of medical research. Avicanna’s medical cannabis care platform MyMedi.ca will providing the necessary infrastructure, patient support, and education for all participating HCPs nationwide. Participating patients will have access to the platform’s products including Avicanna’s own RHO Phyto formulary in addition to products from select licensed producers that are supporting the study.